Teva stock drops 13% as Tel Aviv trade beginsTeva lost due to new competition as Mylan N.V just got the green light to start selling its' own version of Copaxone.A building in Jerusalem belonging to generic drug producer Teva(photo credit: REUTERS/BAZ RATNER)
